Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GGNBP2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | PMPCA | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | PRPF31 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | GLUD2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | CDKN1A | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | TUFT1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | GRB10 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | ALAS2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | HIP1R | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | GLUD1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |